Clinical Trial Update: Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India

View source ↗

Summary

A retrospective medical chart review from India evaluating outcomes of chronic lymphocytic leukemia and mantle cell lymphoma patients treated with ibrutinib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Mantle Cell Lymphoma

Drugs mentioned

• IMBRUVICA (IBRUTINIB)

Snippet

Sponsor: Johnson & Johnson Private Limited | Conditions: Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell | Status: COMPLETED